Advertisement
UK markets close in 5 hours 18 minutes
  • FTSE 100

    8,118.02
    +39.16 (+0.48%)
     
  • FTSE 250

    19,833.42
    +231.44 (+1.18%)
     
  • AIM

    755.57
    +2.45 (+0.33%)
     
  • GBP/EUR

    1.1660
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2517
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    51,524.33
    +706.52 (+1.39%)
     
  • CMC Crypto 200

    1,389.86
    -6.67 (-0.48%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.95
    +0.38 (+0.45%)
     
  • GOLD FUTURES

    2,361.80
    +19.30 (+0.82%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,052.67
    +135.39 (+0.76%)
     
  • CAC 40

    8,041.40
    +24.75 (+0.31%)
     

Company News For Nov 27, 2019

  • Shares of ChemoCentryx, Inc. CCXI gained more than 100% after the clinical-stage biopharmaceutical company reported that the pivotal phase-III ADVOCATE trial of avacopan for treatment of patients with ANCA-associated vasculitis had met both primary endpoints.

  • Shares of Safehold Inc. SAFE rose 6.9% after the company would replace Oritani Financial in the S&P SmallCap 600 on December 3.

  • Shares of Titan Machinery Inc. TITN declined 15.5% after the company reported third quarter earnings of $0.44 per share, which missed the Zacks Consensus Estimate of $0.47.

  • Shares of Hewlett Packard Enterprise Company HPE lost 8.5% after the company’s net revenues of $7.23 billion missed the Zacks Consensus Estimate of $7.46 billion.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hewlett Packard Enterprise Company (HPE) : Free Stock Analysis Report
 
Titan Machinery Inc. (TITN) : Free Stock Analysis Report
 
ChemoCentryx, Inc. (CCXI) : Free Stock Analysis Report
 
Safehold Inc. (SAFE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research